These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 34965375)

  • 1. Dynamic Differences of Immunological Parameters Between Severe and Non-severe COVID-19 Patients.
    Li Q; Xu W; Li W; Huang C; Fei L; Xie X; Chen L
    Discov Med; 2021; 31(163):79-87. PubMed ID: 34965375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
    Li Q; Xu W; Li WX; Huang CL; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of lymphocyte subsets and inflammatory factors in patients with COVID-19.
    Chen Z; Li J; Zheng J; Xiang F; Li X; Zhang M; Kang X; Wu R
    Heliyon; 2024 Mar; 10(6):e28451. PubMed ID: 38545136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.
    Idiz UO; Yurttas TT; Degirmencioglu S; Orhan B; Erdogan E; Sevik H; Sevinc MM
    J Med Virol; 2022 Oct; 94(10):4744-4753. PubMed ID: 35667877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous tracking of COVID-19 patients' immune status.
    Guan J; Wei X; Qin S; Liu X; Jiang Y; Chen Y; Chen Y; Lu H; Qian J; Wang Z; Lin X
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107034. PubMed ID: 33039966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].
    Zhagn S; Li D; Chen H; Zheng D; Zhou Y; Chen B; Shi W; Lin R
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):220-226. PubMed ID: 32391668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological features of severe and moderate coronavirus disease 2019.
    Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
    J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study.
    Kang Y; Lu S; Zhong R; You J; Chen J; Li L; Huang R; Xie Y; Chen F; Chen J; Chen L
    Heliyon; 2024 Jan; 10(1):e23583. PubMed ID: 38173531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].
    Hua R; Chen FX; Zhang YM; Zhou ZH; Wang SJ; Liang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):489-92. PubMed ID: 24021046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
    Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
    Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Acid Suppression on Peripheral T-Lymphocyte Subsets and Immunohistochemical Esophageal Mucosal Changes in Patients With Gastroesophageal Reflux Disease.
    Ahmed Osman H; Aly SS; Mahmoud HS; Ahmed EH; Salah Eldin EM; Abdelrahim EA; El Masry MA; Herdan RA; Hassan MH
    J Clin Gastroenterol; 2019 Oct; 53(9):e362-e370. PubMed ID: 30119091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Counts of Various Subsets of Peripheral Blood T Lymphocytes in Patients with Severe Course of COVID-19.
    Zhao C; Hu X; Xue Q; Chen L
    Bull Exp Biol Med; 2022 Apr; 172(6):721-724. PubMed ID: 35501642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.